Leerink Swann reaffirmed their outperform rating on shares of UnitedHealth Group (NYSE:UNH) in a research report report published on Friday. Leerink Swann also issued estimates for UnitedHealth Group’s FY2018 earnings at $10.85 EPS.

A number of other equities research analysts also recently issued reports on the stock. Jefferies Group reaffirmed a buy rating and set a $248.00 price target on shares of UnitedHealth Group in a research note on Friday. Piper Jaffray Companies increased their target price on shares of UnitedHealth Group to $242.00 and gave the company an overweight rating in a research note on Wednesday, November 29th. Royal Bank Of Canada increased their target price on shares of UnitedHealth Group to $244.00 and gave the company an outperform rating in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Credit Suisse Group reissued a positive rating and issued a $240.00 target price (up previously from $233.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Finally, Oppenheimer increased their target price on shares of UnitedHealth Group from $215.00 to $225.00 and gave the company an outperform rating in a research note on Wednesday, November 29th. Three research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus price target of $224.56.

Shares of UnitedHealth Group (UNH) opened at $221.42 on Friday. The stock has a market cap of $215,080.00, a price-to-earnings ratio of 23.62, a P/E/G ratio of 1.68 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group has a 12 month low of $156.09 and a 12 month high of $231.77.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.17 earnings per share. equities analysts forecast that UnitedHealth Group will post 9.99 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s payout ratio is presently 34.09%.

In other news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now owns 61,137 shares in the company, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 57,606 shares of company stock worth $11,566,525. Company insiders own 0.89% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Institutional & Family Asset Management LLC grew its holdings in UnitedHealth Group by 4.6% during the 3rd quarter. Institutional & Family Asset Management LLC now owns 19,346 shares of the healthcare conglomerate’s stock worth $3,789,000 after acquiring an additional 857 shares in the last quarter. Steward Partners Investment Advisory LLC bought a new position in UnitedHealth Group during the 3rd quarter worth about $7,787,000. Visionary Asset Management Inc. bought a new position in UnitedHealth Group during the 3rd quarter worth about $309,000. Jana Partners LLC bought a new position in UnitedHealth Group during the 3rd quarter worth about $44,601,000. Finally, Public Employees Retirement System of Ohio grew its holdings in UnitedHealth Group by 1.2% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 711,891 shares of the healthcare conglomerate’s stock worth $139,424,000 after acquiring an additional 8,769 shares in the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This report was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://theolympiareport.com/2017/12/05/unitedhealth-group-unh-rating-reiterated-by-leerink-swann.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.